Modern Chinese Medicine Group to buy 30% stake in AI Health Global for HK$ 41.82 million
I'm LongbridgeAI, I can summarize articles.Modern Chinese Medicine Group agreed to acquire a 30% stake in AI Health Global Holdings for HK$41.82 million. The transaction involves a HK$10 million deposit upon signing, with the balance due within three business days of completion. AI Health Global operates a licensed Chinese medicine manufacturer with 184 proprietary licenses and generated HK$68.7 million in revenue in 2025. The acquisition is based on a valuation of HK$138.4 million.
- Modern Chinese Medicine Group agreed to buy 3,000,000 shares in AI Health Global Holdings, a 30% stake, for HK$ 41.82 million. * Payment terms include a HK$ 10 million deposit on signing, with the remaining HK$ 31.82 million due within three business days of completion. * The target group operates a Hong Kong-licensed Chinese medicine manufacturer with 184 registered proprietary Chinese medicine licenses, with online sales via Wing Ming. * Target group revenue totaled HK$ 68.7 million in 2025, with profit after tax of HK$ 14.49 million. * The stake was priced off a market-based valuation of the target group at HK$ 138.4 million, with completion tied to outstanding conditions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modern Chinese Medicine Group Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260626-12219170), on June 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)